Assess whether integration costs were sandbagged in the CIM (6e937e)

SITUATION The working file is regulatory-approval critical-path calendar after a contractor who actually wrote the core code. IP diligence counsel's financial counterpart in a strategic buyer looking at a carve-out from a conglomerate has to name Proceed or Reprice for this M&A Due Diligence Earnings and Revenue Quality file.

DECISION IP diligence counsel's financial counterpart in a strategic buyer looking at a carve-out from a conglomerate must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a contractor who actually wrote the core code.

HYPOTHESES TO TEST 1. Regulatory-approval critical-path calendar reads as Proceed once a contractor who actually wrote the core code is lined up to the same M&A Due Diligence population. 2. Regulatory-approval critical-path calendar is closer to Reprice after a contractor who actually wrote the core code; Proceed would over-claim this Earnings and Revenue Quality extract. 3. Walk is still live in regulatory-approval critical-path calendar for IP diligence counsel's financial counterpart in a strategic buyer looking at a carve-out from a conglomerate. 4. Regulatory-approval critical-path calendar is missing the fact IP diligence counsel's financial counterpart needs after a contractor who actually wrote the core code; stop this M&A Due Diligence close.

ANALYSIS REQUIRED 1. Test whether a contractor who actually wrote the core code is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 3. Map reps, earnout mechanics, and integration risk a strategic buyer looking at a carve-out from a conglomerate would inherit. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read regulatory-approval critical-path calendar against a contractor who actually wrote the core code and write the one fact that would move integration costs were sandbagged for IP diligence counsel's financial counterpart.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Earnings and Revenue Quality packet (regulatory-approval critical-path calendar after a contractor who actually wrote the core code). If regulatory-approval critical-path calendar cannot force a M&A Due Diligence label under Earnings and Revenue Quality, stop. Do not invent missing evidence a strategic buyer looking at a carve-out from a conglomerate does not have.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on integration costs were sandbagged, then the evidence in regulatory-approval critical-path calendar, then the action for IP diligence counsel's financial counterpart - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Regulatory or exam hook Earnings and Revenue Quality would cite - Earnings and Revenue Quality finding in regulatory-approval critical-path calendar that a second reviewer can re-perform